Skip to main content Accessibility help
×
Home

Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes

  • A. KOWADA (a1)

Summary

Tuberculosis (TB) in older people is a significant public health problem in low TB-incidence countries. Older persons have increased TB incidence, higher reactivation and mortality. A delay in diagnosis and initiation of TB treatment in patients with atypical clinical and radiological features is a significant factor of widespread transmission. This study aimed to evaluate the cost-effectiveness of interferon-gamma release assays [IGRAs; QuantiFERON®-TB Gold In-Tube (QFT) and T-SPOT®.TB (T-SPOT)] compared to the tuberculin skin test (TST) and chest X-ray (CXR) examination for TB screening for nursing homes. Decision trees and Markov models were constructed using a societal perspective on a lifetime horizon. Seven strategies: no screening, TST, QFT, T-SPOT, TST followed by QFT, TST followed by T-SPOT, and CXR were considered. QFT [US$ 401·9, 4·36 707 QALY (year 2014 values)] was the most cost-effective at the willingness-to-pay level of US$ 50 000/QALY gained. TST followed by QFT was the most cost-effective in residents with comorbidities. CXR was less cost-effective. Cost-effectiveness was sensitive to latent TB infection (LTBI) rate and bacillus Calmette-Guérin vaccination rate. Effective LTBI screening using IGRA is recommended to prevent TB transmission not only in nursing homes but also in local communities in low-incidence countries.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes
      Available formats
      ×

Copyright

Corresponding author

Address for correspondence: A. Kowada, MD, PhD, General Affairs Department, Ota City, Tokyo, Japan. (Email: kowadaa@gmail.com)

References

Hide All
1. Thrupp, L, et al. SHEA Long-Term-Care Committee. Tuberculosis prevention and control in long-term-care facilities for older adults. Infection Control & Hospital Epidemiology 2004; 25: 10971108.
2. Hochberg, NS, Horsburgh, CR Jr. Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. Clinical Infectious Diseases 2013; 56: 12401247.
3. Pratt, RH, et al. Tuberculosis in older adults in the United States, 1993–2008. Journal of the American Geriatrics Society 2011; 59: 851857.
4. Yoshikawa, TT. Important infections in elderly persons. Western Journal of Medicine 1981; 135: 441445.
5. Rajagopalan, S. Tuberculosis and aging: a global health problem. Clinical Infectious Diseases 2001; 33: 10341039.
6. Rajagopalan, S, Yoshikawa, TT. Tuberculosis in long-term-care facilities. Infection Control & Hospital Epidemiology 2000; 21: 611615.
7. Pai, M, Zwerling, A, Menzies, D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Annals of Internal Medicine 2008; 149: 177184.
8. Diel, R, Loddenkemper, R, Nienhaus, A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010; 137: 952968.
9. Diel, R, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. European Respiratory Journal 2011; 37: 8899.
10. Department of Economic and Social Affairs Population Division of the United Nations. World population, Aging 2013.New York, 2013 (http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf). Accessed 2 April 2016.
11. Ministy of Health, Labour and Welfare. The current institution services of the Long-term care insurance system in Japan. 2013 (http://www.mhlw.go.jp/file.jsp?id=146267&name=2r98520000033t91_1.pdf) [in Japanese]. Accessed 2 April 2016.
12. Fountain, FF, et al. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest 2005; 128: 116123.
13. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bulletin of the World Health Organization 1982; 60: 555564.
14. The Research Institute of Tuberculosis/JATA. The Tuberculosis Surveillance Center. Statistics of TB (http://www.jata.or.jp/rit/ekigaku/en). Accessed 2 April 2016.
15. Horsburgh, CR Jr., et al. Revisiting rates of reactivation tuberculosis: a population-based approach. American Journal of Respiratory and Critical Care Medicine 2010; 182: 420425.
16. Horsburgh, CR Jr., et al. Tuberculosis Epidemiologic Studies Consortium. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 2010; 137: 401409.
17. Wang, CS, et al. The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 2008; 36: 335340.
18. Verma, G, Chuck, AW, Jacobs, P. Tuberculosis screening for long-term care: a cost-effectiveness analysis. International Journal of Tuberculosis and Lung Disease 2013; 17: 11701177.
19. Tuberculosis Surveillance Center; RIT; JATA. Tuberculosis annual report 2012 – (4) Tuberculosis treatment and outcomes [in Japanese]. Kekkaku 2014; 89: 825834.
20. Katsenos, S, et al. Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home. Journal of the American Geriatrics Society 2011; 59: 858862.
21. Ormerod, LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. British Medical Bulletin 2005; 73–74: 1724.
22. Lobue, P, Menzies, D. Treatment of latent tuberculosis infection: an update. Respirology 2010; 15: 603–22.
23. Horsburgh, CR. Jr. Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine 2004; 350: 20602067.
24. Ministry of Health, Labour and Welfare. BCG vaccination rate in Japan (http://www.mhlw.go.jp/topics/bcg/other/5.html) [in Japanese]. Accessed 17 January 2016.
25. Sester, M, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. European Respiratory Journal 2011; 37: 100111.
26. Kowada, A. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients. Nephrolgy Dialysis Transplantation 2013; 28: 682688.
27. Kowada, A. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries. Journal of Infection 2014; 68: 3242.
28. Dobler, CC, Flack, JR, Marks, GB. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. British Medical Journal Open 2012; 2 e000666.
29. Faurholt-Jepsen, D, et al. Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scandinavian Journal of Infectious Diseases 2014; 46: 384391.
30. Tattevin, P, et al. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model. Chest 1999; 115: 12481253.
31. Igakutsushin-sya. National fee schedule and Medical insurance reimbursement table in Japan [in Japanese]. Tokyo: Igakutsushin-sya, 2010.
32. World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva, World Health Organization, 2015.
33. Ministry of Health, Labor and Welfare. Basic survey on wage structure 2014 (http://www.e-stat.go.jp/SG1/estat/GL08020103.do?_toGL08020103_&tclassID=000001054146&cycleCode=0&requestSender=estat) [in Japanese]. Accessed 2 April 2016.
34. Guo, N, Marra, F, Marra, CA. Measuring health-related quality of life in tuberculosis: a systematic review. Health and Quality of Life Outcomes 2009; 7: 14.
35. Dion, MJ, et al. Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Quality of Life Research 2004; 13: 653665.
36. Ijaz, K, et al. Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. Journal of the American Geriatrics Society 2002; 50: 12131218.
37. Chitnis, AS, et al. Trends in tuberculosis cases among nursing home residents, California, 2000 to 2009. Journal of the American Geriatrics Society 2015; 63: 10981104.
38. Kowada, A, et al. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations. Molecular Diagnosis & Therapy 2010; 14: 229236.

Keywords

Related content

Powered by UNSILO

Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes

  • A. KOWADA (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.